HUMAN RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST PREVENTS ADRENOCORTICOTROPIN, BUT NOT INTERLEUKIN-6 RESPONSES TO BACTERIAL-ENDOTOXIN IN RATS

被引:47
|
作者
SCHOTANUS, K [1 ]
TILDERS, FJH [1 ]
BERKENBOSCH, F [1 ]
机构
[1] FREE UNIV AMSTERDAM,FAC MED,NEUROSCI RES INST,DEPT PHARMACOL,VAN DER BOECHORSTR 7,1081 BT AMSTERDAM,NETHERLANDS
关键词
D O I
10.1210/en.133.6.2461
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study was designed to analyze the role of endogenous interleukin-1 (IL-1) in the ACTH, corticosterone (CORT), and IL-6 responses of rats to bacterial endotoxin. Recombinant rat IL-1beta (rIL-1beta) when given ip resulted in dose-dependent increases in plasma ACTH, CORT, and IL-6 concentrations. Plasma ACTH and CORT responses could be induced by low rIL-1beta doses that did not elevate plasma IL-6 levels. The half-maximally effective dose of rIL-1beta was less than 0.6 mug/kg for the ACTH and CORT responses and higher than 2.5 mug/kg for the IL-6 response. Time-course studies indicated that plasma ACTH and CORT concentrations were already elevated 30 min after the injection of rIL-1beta (2.5 mug/kg, ip), with peak values after 1-2 h, followed by a subsequent decline. In contrast, plasma IL-6 concentrations became elevated 2 h after the injection of rIL-10. In another set of experiments, the administration of endotoxin resulted in a dose-dependent elevation of the plasma ACTH, CORT, and IL-6 concentrations. The dose-response characteristics for ACTH, CORT, and IL-6 were different. The half-maximally effective dose for the ACTH and CORT, and IL-6 responses were approximately 2.5 mug/kg and more than 10 mug/kg, respectively. Time courses of plasma ACTH, CORT, and IL-6 responses to endotoxin (2.5 mug/kg, ip) were similar, with peak values measured after 2 h. When given alone, the human IL-1 receptor antagonist (IL-1RA; 1 or 2.5 mg/kg, ip) did not affect resting plasma ACTH and CORT concentrations and reduced plasma IL-6 concentrations in one experiment. At a dose of 1 mg/kg, IL-1RA inhibited ACTH and IL-6 responses to rIL-1beta (2.5 mug/kg, ip) by 75% and 90%, respectively. Administration of IL-1RA (2.5 mg/kg, ip) 30 min after endotoxin (2.5 ug/kg, ip) completely prevented the ACTH response and partially inhibited the CORT response, but did not affect the IL-6 response measured 2.5 h after endotoxin administration. We conclude that 1) IL-1 receptors are involved in the ACTH and IL-6 responses to rat IL-1beta; 2) the ACTH response, but not the IL-6 response, to a low dose dose of endotoxin in rats requires IL-1 receptor activation by endogenous produced IL-1; and 3) circulating IL-6 is not a prime mediator involved in ACTH and CORT responses to low doses of rIL-1beta and endotoxin.
引用
收藏
页码:2461 / 2468
页数:8
相关论文
共 50 条
  • [1] Interleukin-1 receptor antagonist inhibits endotoxin fever and systemic interleukin-6 induction in the rat
    Luheshi, G
    Miller, AJ
    Brouwer, S
    Dascombe, MJ
    Rothwell, NJ
    Hopkins, SJ
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1996, 270 (01): : E91 - E95
  • [2] INTERLEUKIN-6 AND INTERLEUKIN-1 RECEPTOR ANTAGONIST IN ACUTE STROKE
    BEAMER, NB
    COULL, BM
    CLARK, WM
    HAZEL, JS
    SILBERGER, JR
    ANNALS OF NEUROLOGY, 1995, 37 (06) : 800 - 805
  • [3] Differential effects of estradiol on the adrenocorticotropin responses to interleukin-6 and interleukin-1 in the monkey
    Xiao, E
    Xia-Zhang, L
    Ferin, M
    Wardlaw, SL
    ENDOCRINOLOGY, 2001, 142 (07) : 2736 - 2741
  • [4] PITUITARY-ADRENAL AND INTERLEUKIN-6 RESPONSES TO RECOMBINANT INTERLEUKIN-1 IN NEONATAL RATS
    LEVINE, S
    BERKENBOSCH, F
    SUCHECKI, D
    TILDERS, FJH
    PSYCHONEUROENDOCRINOLOGY, 1994, 19 (02) : 143 - 153
  • [5] COMPARATIVE RESPONSES OF HUMAN AND RABBIT INTERLEUKIN-1 INVIVO - EFFECT OF A RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST
    VONUEXKULL, C
    NOURSHARGH, S
    WILLIAMS, TJ
    IMMUNOLOGY, 1992, 77 (04) : 483 - 487
  • [6] Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6
    Daig, R
    Rogler, G
    Aschenbrenner, E
    Vogl, D
    Falk, W
    Gross, V
    Schölmerich, J
    Andus, T
    GUT, 2000, 46 (03) : 350 - 358
  • [7] Interleukin-6, interleukin-1 beta and interleukin-1 receptor antagonist levels in epileptic seizures
    Uludag, Irem Fatma
    Bilgin, Sule
    Zorlu, Yasar
    Tuna, Gamze
    Kirkali, Guldal
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2013, 22 (06): : 457 - 461
  • [8] Interleukin-1 receptor antagonist and interleukin-6 as markers of surgical trauma
    Slotwinski, R
    Lech, G
    Gomula, J
    Zaleska, M
    Malyszka, K
    Szczygiel, B
    5TH WORLD CONGRESS ON TRAUMA, SHOCK, INFLAMMATION AND SEPSIS: PATHOPHYSIOLOGY, IMMUNE CONSEQUENCES AND THERAPY, 2000, : 425 - 430
  • [9] INDUCTION OF INTERLEUKIN-6 BY HUMAN AND MURINE RECOMBINANT INTERLEUKIN-1 IN MICE
    LIBERT, C
    BROUCKAERT, P
    SHAW, A
    FIERS, W
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (03) : 691 - 694
  • [10] INTERLEUKIN-1, INTERLEUKIN-1 RECEPTOR, AND INTERLEUKIN-1 RECEPTOR ANTAGONIST
    ESPAT, NJ
    ROGY, MA
    COPELAND, EM
    MOLDAWER, LL
    PROCEEDINGS OF THE NUTRITION SOCIETY, 1994, 53 (02) : 393 - 400